Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Osteoporosis medicine lowers breast cancer relapse rate

Photo: APA (dpa) © Photo: APA (dpa)

"The results are spectacular“, said lead investigator Michael Gnant, Head of the University Department of Surgery at the Medical University of Vienna at Vienna’s General Hospital, President of the Austrian Breast & Colorectal Cancer Study Group (ABCSG) and Deputy Head of the Comprehensive Cancer Center (CCC; Medical University of Vienna/Vienna General Hospital). 65 treatment centers throughout Austria with a total of 3,425 postmenopausal breast cancer patients took part in the study.

Several years ago, it was already demonstrated that osteoporosis drugs from the class of bisphosphonates can prevent a good percentage of therapy-related bone atrophy. At the same time, use of these drugs can also reduce the rate of recurrence for mammary carcinoma patients.

A meta-analysis of existing data (“The Lancet“) published by Gnant and other authors in July 2015 after a large scale study clearly demonstrated this additional effect. The frequency of bone fractures was reduced by 50 percent. The bone density enhancing anti-osteoporosis therapy led to a 28 percent reduction in bone metastases and an 18 percent decline in the long-term breast cancer mortality rate.     

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Business Location Austria

    24.09.2019, Bucharest, Romania

  • Business Location Austria

    25.09.2019, Cluj-Napoca, Romania

Austria Map

Find the perfect location for your company

Thanks to its central location, excellent infrastructure and high quality staff, Austria is one of the key locations for ZTE Corporation and HQ for the Eastern Europe Region in general.

ZTE Austria

logo zte
More testimonials

news from the business location Austria

ERC Starting Grant for molecular biologist in Innsbruck

The molecular biologist Jerome Mertens received a Starting Grant of the European Research Council (ERC) for his research into understanding the molecular and cellular causes of aging, especially brain aging and molecular cell biology of Alzheimer's disease in nerve cells.

Not Only for Startups: The Business Plan as the Road Map to Success

A great idea has been born. The product the world is waiting for has been invented. Actually, nothing can seemingly go wrong. At least one would be inclined to think so. However, the best idea or invention is worthless without a business plan to successfully bring the idea down to earth. Here you will find out what you should take into consideration when drawing up a business plan.

More news All blog posts